Mr. Speaker, could my colleague comment on some of the cost implications? In my home city of Ottawa, several years ago there was a very powerful debate about a site where we could deal with addiction. I would like to remind my colleagues on the other side of the House that being addicted is the antithesis of being free to make choices, because people are actually addicted.
In our hometown of Ottawa we realized that the cost of treating, for example, one HIV patient over a lifetime was somewhere around $600,000. Maybe my colleague could explain to Canadians why this is an important feature of having a harm-reduction site that minimizes infections and reduces health care costs for the country.